X
Get new exclusive access to healthcare business reports & breaking news
Nqaba Matshazi Nqaba has been working as an investigative journalist for the last 10 years. He has written for various media outlets across the world.
The clinical-stage biopharmaceutical firm Principia Biopharma, which researches and develops pharmaceutical treatments for inflammatory and autoimmune diseases, has ...
EpiPen, the biggest name-brand injector drug used to treat patients with life-threatening allergic reactions, just got its first, ...
Virtual health provider, MDLIVE has closed a $50 million investment round led by Cigna and Health Care Services ...
Privately owned Entasis Therapeutics, a company working on new antibacterial drugs to treat drug-resistant bacterial infections, is going ...
According to reports from CNBC, Apple is putting together a team to create a custom processor that can ...
United Kingdom-based biotech firm, Orchard Therapeutics has closed a successful Series C financing round, during which it raised ...
After raising $50 million from new investors, Boston based startup, Akouos, is set to begin clinical trials for ...
Illinois is being praised in a new report for increasing access to healthcare through Medicaid and for its ...
Swiss-based biotech company, Therachon, which focuses on developing rare genetic disease treatments, says it has closed a $60 ...
